Exposure to HIV-1 during delivery and mother-to-child transmission
- 1 October 2000
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 14 (15) , 2341-2348
- https://doi.org/10.1097/00002030-200010200-00015
Abstract
The correlation between the presence of HIV-1 in maternal cervico-vaginal secretions and in the infant's oro-pharyngal secretions at birth, and mother-to-child HIV transmission (MTCT) were examined to obtain a better understanding of its mechanism. Women without medical and obstetrical complications, living within a reasonable distance of the government hospital in Mombasa, Kenya, were recruited after informed consent. Maternal and infant characteristics were collected. Polymerase chain reaction was used to detect HIV-1 in cervico-vaginal and oro-pharyngal secretions. Infants were tested for HIV-1 by polymerase chain reaction within 48 h and at 6 weeks after delivery. Between April 1998 and April 1999, 228 woman–infant pairs were included in the study. HIV-1 DNA in cervico-vaginal secretions was independently associated with HIV-1 maternal viral load and with infant birth-weight, whereas HIV-1 RNA was associated with maternal viral load and maternal age. HIV-1 DNA in the oro-pharyngal secretions was also independently associated with maternal viral load. MTCT rate at the age of 6 weeks was 23.6%. Intrapartum and early postpartum HIV transmission was independently associated with maternal viral load [adjusted odds ratio (OR), 1.6; 95% confidence interval (CI),1.0–2.7], detection of HIV-1 RNA in cervico-vaginal secretions (adjusted OR, 3.2; 95% CI, 1.5–7.3) and of HIV-1 DNA in oro-pharyngal secretions (adjusted OR, 3.2; 95% CI, 1.1–9.0). As far as is known, this is the first study showing that infant exposure to HIV-1 in the birth canal and the presence of HIV-infected cells in the infant's oro-pharyngal cavity are independently associated with intrapartum and early postpartum MTCT. It supports the hypothesis that MTCT could occur through the oral route.Keywords
This publication has 24 references indexed in Scilit:
- Short‐Course Antenatal Zidovudine Reduces Both Cervicovaginal Human Immunodeficiency Virus Type 1 RNA Levels and Risk of Perinatal TransmissionThe Journal of Infectious Diseases, 2000
- Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trialThe Lancet, 1999
- The Mode of Delivery and the Risk of Vertical Transmission of Human Immunodeficiency Virus Type 1 — A Meta-Analysis of 15 Prospective Cohort StudiesNew England Journal of Medicine, 1999
- Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trialThe Lancet, 1999
- 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trialThe Lancet, 1999
- Oral transmission of HIVAIDS, 1998
- Obstetrical Factors and the Transmission of Human Immunodeficiency Virus Type 1 from Mother to ChildNew England Journal of Medicine, 1996
- Birth order, delivery route, and concordance in the transmission of human immunodeficiency virus type 1 from mothers to twinsThe Journal of Pediatrics, 1995
- Design and evaluation of new, highly sensitive and specific primers for polymerase chain reaction detection of HIV-1 infected primary lymphocytesMolecular and Cellular Probes, 1994
- Risk of human immunodeficiency virus type 1 transmission through breastfeedingThe Lancet, 1992